Cargando…
SMYD2 Regulates Vascular Smooth Muscle Cell Phenotypic Switching and Intimal Hyperplasia via Interaction with Myocardin
The SET and MYND domain-containing protein 2 (SMYD2) is a histone lysine methyltransferase that has been reported to regulate carcinogenesis and inflammation. However, its role in vascular smooth muscle cell (VSMC) homeostasis and vascular diseases has not been determined. Here, we investigated the...
Autores principales: | Zhou, Yu, Sharma, Shaligram, Sun, Xiaonan, Guan, Xiaoqing, Hou, Yuning, Yang, Zhe, Shi, Hang, Zou, Ming-Hui, Song, Ping, Zhou, Jiliang, Wang, Shenming, Hu, Zuojun, Li, Chunying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120764/ https://www.ncbi.nlm.nih.gov/pubmed/37090651 http://dx.doi.org/10.21203/rs.3.rs-2721176/v1 |
Ejemplares similares
-
Epithelial SMYD5 Exaggerates IBD by Down-regulating Mitochondrial Functions via Post-Translational Control of PGC-1α Stability
por: Hou, Yuning, et al.
Publicado: (2022) -
YY1 directly interacts with myocardin to repress the triad myocardin/SRF/CArG box-mediated smooth muscle gene transcription during smooth muscle phenotypic modulation
por: Zheng, Jian-Pu, et al.
Publicado: (2020) -
Vascular smooth muscle cells in intimal hyperplasia, an update
por: Déglise, Sébastien, et al.
Publicado: (2023) -
Inhibition of SRF/myocardin reduces aortic stiffness by targeting vascular smooth muscle cell stiffening in hypertension
por: Zhou, Ning, et al.
Publicado: (2017) -
SMYD proteins in immunity: dawning of a new era
por: Doughan, Maysaa, et al.
Publicado: (2016)